Doctor profile · Federal record
Dr. MICHAEL KROWKA, M.D.
Pulmonary Disease Physician (CMS: PULMONARY DISEASE) · ROCHESTER, MN
- NPI 1588640528
- Accepts Medicare
- 46 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
200 1ST ST SW
ROCHESTER, MN 559050001
(507) 284-2511
Credentials & registration
- NPI registered
- December 2005 — 21 yrs on file
- Profile last updated
- August 14, 2020
- Year of graduation
- 1980 — 46 yrs since
- Specialty taxonomy
- 207RP1001X — NUCC code
- State license (1)
- Minnesota #28169
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1588640528. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
92
Distinct HCPCS
3
Medicare allowed
$14,482
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 53 | 44 | $171 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 24 | 21 | $127 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 15 | 15 | $157 |
In context: peer comparison
Among 48 peers in this city , average services per provider: 57. This provider delivers 1.6× the peer median.Open Payments
Industry payments received
All-time total
$18
Transactions
1
Manufacturers
1
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18.28 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
290
Patients
22
Total drug cost
$2,606,105
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Opsumit (Macitentan) | Brand | 97 | 11 | $1,236,654 |
| Tadalafil | Generic | 44 | 0 | $50,295 |
| Furosemide | Generic | 36 | 11 | $205 |
| Ambrisentan | Generic | 34 | 0 | $199,392 |
| Uptravi (Selexipag) | Brand | 29 | 0 | $707,104 |
| Sildenafil Citrate | Generic | 20 | 0 | $5,679 |
| Tyvaso Dpi (Treprostinil) | Brand | 16 | 0 | $395,601 |
| Eliquis (Apixaban) | Brand | 14 | 0 | $11,174 |